Tempus Announces the Acquisition of Paige

About this update from Ai, Inc.

[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/04363e4ba7be2dfbcc377c9a4e0ad773"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Gry6dUWcHQvYPaea3bJAIw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/04363e4ba7be2dfbcc377c9a4e0ad773","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/noK1yJjtSPixN8NCKdnjlw--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/04363e4ba7be2dfbcc377c9a4e0ad773","width":1024,"height":512}},"lazy":false},{"type":"text","content":"Paige’s strong foundation in pathology and AI is rooted in its proprietary dataset of almost 7 million digitized pathology slides that are clinically annotated ","length":159,"tagName":"p","attribs":{}},{"type":"text","content":"CHICAGO, August 22, 2025--(BUSINESS WIRE)--Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced the acquisition of Paige, an AI company specializing in digital pathology. The acquisition allows Tempus to grow its dataset, expand its experienced technical team, and establish a strong footprint in digital pathology with an industry leading technology portfolio.","length":434,"tagName":"p"},{"type":"text","content":"Founded in 2017, Paige has developed and deployed several AI applications, including the first FDA-cleared AI application in pathology, allowing researchers and pathologists to better detect cancer, which enables care teams to make more precise and informed treatment decisions. Paige has developed and refined its products through a dataset that includes almost 7 million digitized pathology slide images and associated clinical and molecular data, stripped of patient identifiers to protect privacy. Leveraging a dataset of de-identified data and images that spans 45 countries and diverse genders, races, ethnicities, and regions, Paige has also developed the first million-slide foundation model for cancer, empowering researchers and life sciences companies to better understand pathology data, and enabling the advancement of drug discovery and development.","length":863,"tagName":"p"},{"type":"text"...

More updates from Ai, Inc.